Krystal Biotech
KRYS
KRYS
298 hedge funds and large institutions have $4.93B invested in Krystal Biotech in 2025 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 87 increasing their positions, 113 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 264 → 298 (+34)
1.69% less ownership
Funds ownership: 96.57% → 94.88% (-1.7%)
23% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 113
Holders
298
Holding in Top 10
7
Calls
$54.2M
Puts
$17.6M
Top Buyers
| 1 | +$61.4M | |
| 2 | +$33.7M | |
| 3 | +$31.2M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$22.9M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$17.2M |
Top Sellers
| 1 | -$45.4M | |
| 2 | -$27.8M | |
| 3 | -$26.6M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$19.1M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$16.8M |